<!DOCTYPE html>
<html>
  <head>
    <title>Hypertension</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/cardiovascular/">cardiovascular</a></li>
      <li><a href="/notes/cardiovascular/cardiovasulcar risk management/">cardiovasulcar risk management</a></li>
      <li class="active">Hypertension</li>
  </ol>

  <div class="page-header">
 
    <h1>Hypertension</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Hypertension</strong></a>
          <div class="toc">
<ul>
<li><a href="#individual-assessment">Individual assessment</a></li>
<li><a href="#definition">Definition</a></li>
<li><a href="#management">Management</a><ul>
<li><a href="#lifestyle">Lifestyle</a></li>
<li><a href="#pharmacological">Pharmacological</a><ul>
<li><a href="#step-1">Step 1:</a></li>
<li><a href="#step-2">Step 2:</a></li>
<li><a href="#step-3">Step 3:</a></li>
<li><a href="#betablockers">Betablockers</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#resistant-hypertension">resistant hypertension</a></li>
<li><a href="#antihypertensive-in-very-elderly">Antihypertensive in very elderly</a></li>
<li><a href="#after-mi">After MI</a></li>
<li><a href="#after-stroke-or-tia">After stroke or TIA</a><ul>
<li><a href="#acute-blood-pressure-lowering-therapy">Acute blood pressure lowering therapy</a></li>
<li><a href="#secondary-prevention">Secondary prevention</a></li>
<li><a href="#lifestyle_1">Lifestyle</a></li>
</ul>
</li>
<li><a href="#aged-6275yo">Aged >75yo</a></li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <p>BPAC BPJ 2013 54</p>
<p>primary care handbook 2012/2013</p>
<h3 id="individual-assessment">Individual assessment</h3>
<ul>
<li>
<p>CVRA underestimate risk in younger adults when blood pressure only significant risk factor</p>
</li>
<li>
<p>short-rem risk assessment influenced by age</p>
</li>
<li>
<p><strong>presence of end organ damage</strong> = important factor when making treatment decisions in patients when traditional risk scores do no indicate high overall CVRA</p>
</li>
</ul>
<h3 id="definition">Definition</h3>
<ul>
<li>
<p>every 2mmHg increase in sBP:</p>
<ul>
<li>risk of death from IHD and stroke increase by 7% and 10%</li>
</ul>
</li>
</ul>
<blockquote>
<ul>
<li>
<p>intermediate BP = 120-139/80-89</p>
</li>
<li>
<p>stage 1: clinic ≥ 140/90 or average daytime ambulatory BP ≥ 135/85</p>
</li>
<li>
<p>stage 2: clinic ≥ 160/100 or average ambulatory ≥ 150/95</p>
</li>
<li>
<p>Severe: clinic sB{P ≥ 180 or dBP ≥ 110</p>
</li>
<li>
<p>Isolated systolic: sBP ≥ 160 and dBP \&lt;90</p>
</li>
<li>
<p>Isolated diastolic: dBP ≥ 90 and sBP \&lt;140</p>
</li>
</ul>
</blockquote>
<ul>
<li>
<p>take two different arms</p>
</li>
<li>
<p>use higher of arms</p>
</li>
<li>
<p>conssitent differences of >10mmHg = increase cardiovascular risk</p>
</li>
<li>
<p>if hypertension</p>
<ul>
<li>
<p>confirm diagnosis</p>
</li>
<li>
<p>assess CVRA</p>
</li>
<li>
<p>determine any end organ damage</p>
<ul>
<li>
<p>dipstick urine</p>
</li>
<li>
<p>ACR</p>
</li>
<li>
<p>eGFR, HbA1c, lipis, urate, electrolyteis</p>
</li>
<li>
<p>Opthalmoscopy</p>
<ul>
<li>
<p>copper/silver wiring</p>
</li>
<li>
<p><a href="../images/AVnipping">AV nipping</a></p>
</li>
<li>
<p>retinal haemorrhages</p>
</li>
</ul>
</li>
<li>
<p>ECG</p>
</li>
</ul>
</li>
<li>
<p>detect causes of secondary hypertension</p>
<ul>
<li>
<p>EtOH</p>
</li>
<li>
<p>recent caffeine</p>
</li>
<li>
<p>OSA</p>
</li>
<li>
<p>Medicines</p>
<ul>
<li>
<p>OCP</p>
</li>
<li>
<p>steroids/oestrogen</p>
</li>
<li>
<p>NSAIDs</p>
</li>
<li>
<p>decongestants</p>
</li>
</ul>
</li>
<li>
<p>Drug missue</p>
<ul>
<li>
<p>amphetamine</p>
</li>
<li>
<p>cocaine</p>
</li>
</ul>
</li>
<li>
<p>Renal parenchymal disease</p>
<ul>
<li>
<p>GN</p>
</li>
<li>
<p>polycystic kidney disease</p>
</li>
</ul>
</li>
<li>
<p>Renal artery stenosis</p>
</li>
<li>
<p>Primary hyperaldosterism (Conn’s syndrome)</p>
<ul>
<li>
<p>significantly raised BP</p>
</li>
<li>
<p>hypokalaemia</p>
</li>
<li>
<p>FHx</p>
</li>
</ul>
</li>
<li>
<p>Cushing’s syndrome</p>
</li>
<li>
<p>Phaeochromocytoma</p>
</li>
<li>
<p>coarctation of aorta</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>if severe hypertension = start prior to confirmation</p>
</li>
</ul>
<h3 id="management">Management</h3>
<ul>
<li>
<p>taget BP \&lt;140/90 appropriate for most people under 80</p>
</li>
<li>
<p>if DM/CKD/cardiovascular disease target \&lt;130/80</p>
</li>
<li>
<p>\&lt;120 associated with increase serious afdverse effects in T2 DM</p>
</li>
<li>
<p>>80yo - target \&lt;150/90</p>
</li>
</ul>
<h4 id="lifestyle">Lifestyle</h4>
<ul>
<li>
<p>weight</p>
</li>
<li>
<p>exercise</p>
</li>
<li>
<p>etoh</p>
</li>
<li>
<p>smoking</p>
</li>
<li>
<p>diet</p>
<ul>
<li>
<p>Salt</p>
<ul>
<li>
<p>\&lt;5g/day = improvement 4-5mmHg sBP</p>
</li>
<li>
<p>aim 1600mg sodium (4g of salt)</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="pharmacological">Pharmacological</h4>
<ul>
<li>
<p>indications</p>
</li>
<li>
<p>Patients with BP ≥ 160/100 </p>
</li>
<li>
<p>Any patients with evidence of any:</p>
<ol>
<li>
<p>target organ damage</p>
</li>
<li>
<p>cardiovascualr disease</p>
</li>
<li>
<p>renal disease</p>
</li>
<li>
<p>diabetes</p>
</li>
<li>
<p>five year CVRA ≥ 20% - see new cvra</p>
</li>
</ol>
</li>
<li>
<p>Adding combination early often results in increase numer of patients responding more quickly compared to monotherapy</p>
</li>
<li>
<p>also synergies</p>
</li>
</ul>
<h5 id="step-1">Step 1:</h5>
<ul>
<li>
<p>\&lt;55yo</p>
<ul>
<li>
<p>ACEi/ARB</p>
</li>
<li>
<p>(not together)</p>
<ul>
<li>
<p>Cilazapril 500mcg -1mg od (max 5mg/day)</p>
</li>
<li>
<p>Quinapril 10mg od (max 40mg in divided doses)</p>
</li>
<li>
<p>Enalapril 5mg od (maintenece 20mg, max40mg/day)</p>
</li>
<li>
<p>Lisinopril 5mg OD (max 8mg)</p>
</li>
</ul>
</li>
<li>
<p>ARB</p>
<ul>
<li>
<p>Candesartan 8mg od (max 32mg/day)</p>
</li>
<li>
<p>Losartan 50mg OD (increase to 100mg od after weeks)</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>≥ 55yo</p>
<ul>
<li>
<p>CCB</p>
<ul>
<li>
<p>provide greater benefit</p>
</li>
<li>
<p>Felodipine 5mg od mane (2.5 elderly 5-10mg od)</p>
</li>
<li>
<p>Amlodipine 5mg od (max 10mg/day)</p>
</li>
<li>
<p>Diltiazem CD - 120-180mg OD - max 240-360mg/day</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h5 id="step-2">Step 2:</h5>
<ul>
<li>
<p>Add ACEi or CCB (depending on what started)</p>
<ul>
<li>
<p>ACCOMPLISH:</p>
<ul>
<li>ACEi (benazepril)  + CCB (amlodipine)>> ACEi + thiazide (hydrochlortiazide)</li>
</ul>
</li>
</ul>
</li>
</ul>
<h5 id="step-3">Step 3:</h5>
<ul>
<li>
<p>Add thazide</p>
<ul>
<li>
<p>indapamide 2.5mg mane</p>
</li>
<li>
<p>chlorthalidone 12.5-25mg od</p>
</li>
<li>
<p>strongest evidence compared to bendrofluazide</p>
</li>
<li>
<p>may help reduce peipheral oedema associated with CCB?</p>
</li>
<li>
<p>increase incidence of new-onset DM</p>
<ul>
<li>especially when combined with Beta-blocker</li>
</ul>
</li>
</ul>
</li>
</ul>
<h5 id="betablockers">Betablockers</h5>
<ul>
<li>
<p>not recommended inital treatment</p>
</li>
<li>
<p>don’t reduce risk of stroke</p>
</li>
<li>
<p>generally pporly tolerated</p>
</li>
</ul>
<h3 id="resistant-hypertension">resistant hypertension</h3>
<ul>
<li>
<p>if ACEi + CCB + diuretic</p>
</li>
<li>
<p>max adherence, lifestyle</p>
</li>
<li>
<p>secondary causes considered</p>
</li>
</ul>
<h3 id="antihypertensive-in-very-elderly">Antihypertensive in very elderly</h3>
<ul>
<li>
<p>HYVET</p>
</li>
<li>
<p>if over 80 life expectancy = 8-10yrs</p>
</li>
<li>
<p>treatment substantially reduce risk of death</p>
</li>
<li>
<p>if lower bp to 150/80</p>
<ul>
<li>
<p>stroke reduced by 30%</p>
</li>
<li>
<p>heart failure mortality decrease 64% </p>
</li>
<li>
<p>all cause 21%</p>
</li>
</ul>
</li>
<li>
<p>don’t withold on basis of age alone</p>
</li>
<li>
<p>consider orthostatic BP</p>
</li>
</ul>
<h3 id="after-mi">After MI</h3>
<ul>
<li>
<p>beta blockers reduce total mortality, cardiovascular mortality and morbidity</p>
</li>
<li>
<p>all people with betablocker</p>
</li>
<li>
<p>consider ACEi</p>
<ul>
<li>especially if any significant left ventricular impairment</li>
</ul>
</li>
<li>
<p>aspirin adn statin</p>
</li>
</ul>
<h3 id="after-stroke-or-tia">After stroke or TIA</h3>
<h4 id="acute-blood-pressure-lowering-therapy">Acute blood pressure lowering therapy</h4>
<ul>
<li>
<p>don’t treat unless extremely high</p>
<ul>
<li>
<p>>220/120 ischaemic</p>
</li>
<li>
<p>>180/100 haemorrhagic</p>
<ul>
<li>
<p>reduce cautiously</p>
<ul>
<li>10-20% max and monitored for signs of neurological detioration</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>continue usual medicines as long as no symptomatic hypotension</p>
</li>
</ul>
<h4 id="secondary-prevention">Secondary prevention</h4>
<ul>
<li>
<p>long term anticoagulation</p>
</li>
<li>
<p>OAC - if AF or cardioembolic stroke and no CI</p>
</li>
<li>
<p>antihypertensive</p>
<ul>
<li>
<p>regardless of BP</p>
</li>
<li>
<p>unless CI by symptomatic hypotension</p>
</li>
<li>
<p>ACEi = direct evidecne</p>
</li>
</ul>
</li>
</ul>
<h4 id="lifestyle_1">Lifestyle</h4>
<ul>
<li>
<p>every person</p>
<ul>
<li>
<p>smoking cessation</p>
</li>
<li>
<p>improving diet</p>
</li>
<li>
<p>increasing regular exercise</p>
</li>
</ul>
</li>
</ul>
<h3 id="aged-6275yo">Aged >75yo</h3>
<ul>
<li>
<p>risk increase with age</p>
</li>
<li>
<p>greater potential to benefit</p>
</li>
<li>
<p>isolated raised systolic hypertnsion</p>
<ul>
<li>
<p>increase risk of ischaemic stroke</p>
<ul>
<li><strong>should be managed aggressively</strong></li>
</ul>
</li>
</ul>
</li>
<li>
<p>generally tolerate as well as younger people</p>
</li>
<li>
<p>postural hyptension common</p>
<ul>
<li>alpha blockers used with great caution</li>
</ul>
</li>
</ul>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
